Separation of the contributions to the magnetization of Tm1 − x Yb x B12 solid solutions in steady and pulsed magnetic fields

The magnetization of substitutional Tm_{1 ? x} Yb _x B₁₂ solid solutions is studied in the composition range 0 < x ≤ 0.81. The measurements are performed at low temperatures (1.9–300 K) in steady (up to 11 T) and pulsed (up to 50 T, pulse duration of 20–100 ms) magnetic fields. An analysis of the experimental data allowed the contributions to the magnetization of the paramagnetic phase of the Tm_{1 ? x} Yb _x B₁₂ compounds to be separated. These contributions include a Pauli component, which corresponds to the response of the heavy-fermion manybody states that appears in the energy gap in the vicinity of the Fermi level (density of states (3?4) × 10²¹ cm^?3 meV^?1), and a contribution with saturation in high magnetic fields attributed to the localized magnetic moments ((0.8–3.7)μ_B per unit cell) of the nanoclusters formed by rare-earth ions with an antiferromagnetic interaction.     

Enantioselective LC–ESI–MS/MS method for quantitation of (−)-lumefantrine and (+)-lumefantrine in mice plasma and application to a pharmacokinetic study

We developed and validated a simple, sensitive, selective, and reliable LC–MS/MS–ESI method for the direct quantitation of lumefantrine (LFN) enantiomers [(−)-LFN and (+)-LFN] in mice plasma as per regulatory guideline. LFN enantiomers and carbamazepine (internal standard) were extracted from mice plasma using Strata X SPE (solid-phase extraction) cartridges. Good resolution between enantiomers was achieved on a Chiralpak IA-3 column using an isocratic mobile phase (0.1% of diethyl amine in methanol), which was delivered at a flow rate of 0.8 mL/min. Detection and quantitation were performed using multiple reaction monitoring mode following the transitions m/z 530.27 → 512.30 and 237.00 → 194.00 for LFN enantiomers and the internal standard, respectively, in the positive-ionization mode. The proposed method provided accurate and reproducible results over the linearity range of 2.39–895 ng/mL for each enantiomer. The intra- and inter-day precisions were in the range of 1.03–6.14 and 6.36–8.70 and 2.03–4.88 and 5.82–11.5 for (−)-LFN and (+)-LFN, respectively. Both (−)-LFN and (+)-LFN were found to be stable under different stability conditions. The method was successfully used to delineate stereoselective pharmacokinetics of LFN enantiomers in mice after an oral administration of rac-LFN (20 mg/kg). The pharmacokinetic results indicated that the disposition of LFN enantiomers was stereoselective in mice.     

Simultaneous determination of colchicine and febuxostat in rat plasma: Application in a rat pharmacokinetic study

A selective, sensitive and rapid LC–MS/MS method has been developed and validated as per US Food and Drug Administration regulatory guidelines for the simultaneous quantitation of colchicine and febuxostat in rat plasma. Colchicine and febuxostat were extracted from the rat plasma using 10% tert-butyl methyl ether in ethyl acetate using colchicine-d₆ as an internal standard (IS). The chromatographic separation of colchicine, febuxostat and the IS was achieved using a mobile phase comprising 5 mm ammonium formate and 0.025% formic acid in acetonitrile (20:80, v/v) in isocratic mode on an Eclipse XDB-C₁₈ column. The injection volume and flow rate were 5.0 μl and 0.9 ml/min, respectively. Colchicine and febuxostat were detected by positive electrospray ionization in multiple reaction monitoring mode using transition pairs (Q1 → Q3) of m/z 400.10 → 358.10 and 317.05 → 261.00, respectively. The assay was linear in the ranges of 0.25–254 and 2.60–622 ng/ml for colchicine and febuxostat, respectively. The inter- and intra-day precision values were 0.58–13.0 and 1.03–4.88% for colchicine and febuxostat, respectively. No matrix or carryover effects were observed during the validation. Both analytes were stable on the bench-top, in the autosampler and in storage (freeze–thaw cycles and long-term storage at −80 ° C). A pharmacokinetic study in rats was performed to show the applicability of the validated method.     

Validated LC–MS/MS method for quantitation of a selective JAK1 inhibitor,filgotinib in rat plasma,and its application to a pharmacokinetic study in rats

Filgotinib is a selective JAK1 (Janus kinase) inhibitor, filed in Japan for the treatment of rheumatoid arthritis. In this paper, we report a validated liquid chromatography coupled with tandem mass spectrometry for the quantification of filgotinib in rat plasma using tofacitinib as an internal standard (IS) as per the Food and Drug Administration regulatory guidelines. Filgotinib and the IS were extracted from rat plasma using ethyl acetate as an extraction solvent and chromatographed using an isocratic mobile phase (0.2% formic acid:acetonitrile; 20:80, v/v) at a flow rate of 0.9 mL/min on a Gemini C₁₈ column. Filgotinib and the IS were eluted at ~1.31 and 0.89 min, respectively. The MS/MS ion transitions monitored were m/z 426.3 → 291.3 and m/z 313.2 → 149.2 for filgotinib and the IS, respectively. The calibration range was 0.78–1924 ng/mL. No matrix effect and carryover were observed. Intra- and inter-day accuracies and precisions were within the acceptance range. Filgotinib was stable for three freeze–thaw cycles: on bench-top up to 6 h, in an autosampler up to 21 h, and at −80 ° C for 1 month. This novel method has been applied to a pharmacokinetic study in rats.     

High-performance liquid chromatography and thin-layer chromatography for the simultaneous quantitation of rabeprazole and mosapride in pharmaceutical products

Simple, sensitive high-performance liquid chromatography (HPLC) and thin-layer chromatography (TLC) methods are developed for the quantitative estimation of rabeprazole and mosapride in their combined pharmaceutical dosage forms. In HPLC, rabeprazole and mosapride are chromatographed using 0.01M 6.5 pH ammonium acetate buffer-methanol-acetonitrile (40:20:40, v/v, pH 5.70+/-0.02) as the mobile phase at a flow rate of 1.0 mL/min. In TLC, the mobile phase is ethyl acetate-methanol-benzene (2:0.5:2.5, v/v). Both the drugs are scanned at 276 nm. The retention times of rabeprazole and mosapride are found to be 4.93+/-0.01 and 9.79+/-0.02, respectively. The Rf values of rabeprazole and mosapride are found to be 0.42+/-0.02 and 0.61+/-0.02, respectively. The linearities of rabeprazole and mosapride are in the range of 400-2000 ng/mL and 300-1500 ng/mL, respectively, for HPLC; in TLC, the linearities of rabeprazole and mosapride are in the range of 400-1200 ng/spot and 300-900 ng/spot, respectively. The limit of detection is found to be 97.7 ng/mL for rabeprazole and 97.6 ng/mL for mosapride in HPLC; in TLC the limit of detection is found to be 132.29 ng/spot for rabeprazole and 98.25 ng/spot for mosapride. The proposed methods can be applied to the determination of rabeprazole and mosapride in combined pharmaceutical products.     

Recent developments in thio‐, seleno‐, and telluro‐ether ligand chemistry

New routes developed recently to overcome the difficulties usually associated with the sequential introduction of Te centers into polytelluro‐ethers and the introduction of tellurium into macrocyclic compounds are described, including the synthesis of the first facultative telluro‐ethers, RTe(CH₂)₃Te(CH₂)₃TeR, R = Me or Ph, and the first tridentate S₂Te‐donor macrocycles and a tetradentate S₃Te‐donor macrocycle. The first systematic investigations into the preparation and characterization of coordination complexes of MX₃ (M = As, Sb, Bi; X = Cl, Br, I) involving polydentate and macrocyclic thio‐ and seleno‐ether ligands are then discussed. The structures of examples of each class of compound are described, including the first examples of seleno‐ether adducts of the group 15 acceptors. A more limited range of telluro‐ether derivatives has been identified and the structure of the first example of this type is included. These species serve to demonstrate the wide structural diversity exhibited by these systems and the factors directing the assembly of these structures are highlighted. © 2002 Wiley Periodicals, Inc. Heteroatom Chem 13:550–560, 2002; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/hc.10100     

Magnetic Anisotropy of the Low-Temperature Specific Heat of Ho0.01Lu0.99B12 with Dynamic Charge Stripes

JETP Letters - The specific heat of Ho0.01Lu0.99B12 single crystals with dynamic charge stripes is studied at low and ultralow temperatures (0.07–20 K) in applied magnetic fields of 0–9...     

Features of the Crystal Structure of Tm1–xYbxB12 Dodecaborides near a Quantum Critical Point and at a Metal–Insulator Transition

JETP Letters - The magnetic phase diagram of Tm1–xYbxB12 antiferromagnets is determined from the specific heat measurements performed at low and ultralow temperatures (0.07–10 K)....     

Diorganotin(IV) complexes of polyaromatic azo‐azomethine ligand derived from salicylaldehyde and ortho‐aminophenol: Synthesis,characterization, and molecular structures

The diorganotin(IV) complexes of methyl 2‐{4‐hydroxy‐3‐[(2‐hydroxy‐phenylimino)‐methyl]‐phenylazo}‐benzoate (H2L) were obtained by the reaction of ortho‐aminophenol, R₂SnO (R = Me, ⁿBu, or Ph) and methyl 2‐[(E)‐(3‐formyl‐4‐hydroxy)diazenyl]benzoate (H2PL²) in ethanol, which led to diorganotin(IV) compounds of composition [Me₂SnL]₂ ( 1 ), ⁿBu₂SnL ( 2 ), and Ph₂SnL ( 3 ) in good yield. The ¹H, ¹³C, and ¹¹⁹Sn NMR, IR, the mass spectrometry along with elemental analyses allowed establishing the structure of ligand (H2L) and compounds 1–3 . In all the three cases, ¹¹⁹Sn chemical shifts are indicators of five‐coordinated Sn atoms in a solution state. The crystal structures of ligand H2L and complexes 1 and 2 were determined by a single crystal X‐ray diffraction study. In the solid state, the ligand H2L exists as a keto‐enamine tautomeric form. The molecular structure of complex 1 in the solid state shows a distorted octahedral geometry around a tin atom due to additional coordination with an oxygen atom from a neighboring molecule leading to a four‐membered ring with Sn‐O···Sn‐O intermolecular coordination, leading to a dimeric species. On the other hand, complex 2 is a monomer with trigonal bipyramidal geometry surrounding the tin atom. © 2012 Wiley Periodicals, Inc. Heteroatom Chem 23:457–465, 2012; View this article online at wileyonlinelibrary.com . DOI 10.1002/hc.21037